New Additions to the Aegis Behavioral Health Testing Menu

Register for our Next Live Webinar Presentation

Join us for a brief educational session highlighting recent enhancements to the Aegis behavioral health testing menu. Dr. Chris Burke will cover key clinical insights on newly added analytes—lemborexant, viloxazine, benztropine, trihexyphenidyl and lumateperone—and their significance in behavioral health care.

Dr. Burke will delve into the clinical relevance of these additions, highlighting their pharmacologic profiles, therapeutic applications, and implications for patient care in behavioral health settings.

Learning Objectives
• Understand pharmacologic profiles
• Recognize indications for use
• Identify their role in therapy
• Interpret sample laboratory reports incorporating these new analytes